Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection has driven strong sales, contributing to the company’s overall revenue ...

Oklahoma reports declines in adult and childhood obesity, citing state initiatives and community programs for healthier lifestyles.

NVO files an NDA with the FDA for once-weekly CagriSema, a combo obesity injection showing superior weight loss in obese patients in phase III studies.

Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.

Scientists are closing in on the brain’s internal circuitry for hunger, revealing a surprisingly precise “off switch” that ...

The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.

Are pickles bad for blood pressure? Yes, eating pickles every day increase your blood sodium levels and raise blood pressure, putting you at risk of hypertension.

The number of US adults living with heart failure has more than doubled over the past three decades, mostly due to the rising ...

If our leaders heed this call, we can help ensure that obesity treatments remain tools of healing, not shortcuts to danger.

The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...